Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysis

BACKGROUND: Warfarin is traditionally the drug of choice for stroke prophylaxis or treatment of venous thromboembolism in patients with end-stage renal disease (ESRD) on hemodialysis as data on apixaban use is scarce. We aimed to assess the safety and efficacy of Apixaban in patients with ESRD on he...

Descripción completa

Detalles Bibliográficos
Autores principales: Murtaza, Ghulam, Turagam, Mohit K., Garg, Jalaj, Boda, Urooge, Akella, Krishna, Velagapudi, Poonam, Natale, Andrea, Gopinathannair, Rakesh, Lakkireddy, Dhanunjaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263313/
https://www.ncbi.nlm.nih.gov/pubmed/33866017
http://dx.doi.org/10.1016/j.ipej.2021.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263313/
https://www.ncbi.nlm.nih.gov/pubmed/33866017
http://dx.doi.org/10.1016/j.ipej.2021.04.002

Ejemplares similares